Manchester Capital Management »

Cidara Therapeutics shares owned by Manchester Capital Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Manchester Capital Management from 13F filings

Historical chart of Manchester Capital Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Manchester Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Manchester Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.6k 470 11.94

More positions owned by Manchester Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
United Parcel Service CL B (UPS)
Apple (AAPL)
T. Rowe Price (TROW)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ftai Aviation SHS (FTAI)
Ishares Tr Msci Kld400 Soc (DSI)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Manchester Capital Management

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Russell Investments
Tower Research Capital
Manchester Capital Management
Pacifica Partners

View all funds holding Cidara Therapeutics